Nebulized Pulmicort verified safe for kids’ asthma
|
Tweet
|
|
Inhalation of the corticosteroid budesonide (Pulmicort) via a nebulizer to treat asthma in children does not cause any problems with infection, cataracts, or growth, according to pooled data from a number of clinical trials.
The findings, lead author Stanley J. Szefler told Reuters Health, “provide reassuring information from a large database on the safety of this medication for use in the management of childhood asthma.”
A nebulizer may be particularly suitable for treating asthma in children because, unlike pressurized metered-dose inhalers, it requires little coordination and no voluntary control of respiration.
Pulmicort Respules are the only form of inhaled corticosteroids approved by the FDA for use in nebulizers, and approved for treating children 1 to 8 years old, Dr. Szefler of the National Jewish Medical and Research Center, Denver, and colleagues note in the Annals of Allergy, Asthma and Immunology.
The researchers examined information on the safety of Pulmicort inhalation therapy in patients 18 years or younger from the databases of AstraZeneca, the drug’s manufacturer.
The data covered nine clinical trials involving close to 1700 subjects, and information gathered since the worldwide approval of budesonide inhalation suspension in 1990.
Szefler’s team found that there were no increased risks of cataracts, throat and mouth problems, or infections among children treated with nebulized Pulmicort.
There was only a “small” difference in short-term growth between children who did and did not get Pulmicort treatment in two of the five trials that looked at this factor.
So, the researchers conclude that short- and long-term treatment with the agent, using a wide range of doses, “is safe and well tolerated in children with asthma.”
SOURCE: Annals of Allergy, Asthma and Immunology, July 2004.
Revision date: July 3, 2011
Last revised: by Amalia K. Gagarina, M.S., R.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

